| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SERES THERAPEUTICS INC | 12,682,876 | 125,560,000 | 40.85% | ||
| 2 | SYROS PHARMACEUTICALS INC | 4,806,656 | 58,449,000 | 19.02% | ||
| 3 | EDITAS MEDICINE INCORPORATED | 3,455,316 | 56,080,000 | 18.25% | ||
| 4 | AGIOS PHARMACEUTICALS INC | 965,369 | 40,285,000 | 13.11% | ||
| 5 | SELECTA BIOSCIENCES INC | 826,862 | 14,181,000 | 4.61% | ||
| 6 | T2 BIOSYSTEMS INC | 1,950,583 | 10,260,000 | 3.34% | ||
| 7 | ELEVEN BIOTHERAPEUTICS INC | 1,324,018 | 2,529,000 | 0.82% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-17-000113, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
